Zobrazeno 1 - 10 of 26 pro vyhledávání: '"J. Relakis"'
3
A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women
Autor: Nikos Maniadakis, M.V. Holm, Stathis Kontodimas, Georgia Kourlaba, J. Relakis
Publikováno v: J Travel Med
Background Pregnancy-related venous thromboembolism (VTE) is one of the leading causes of maternal morbidity and mortality. Objectives To review the epidemiology, and humanistic and economic burden of pregnancy-related VTE. Search strategy Medline, t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1422e2142ff48502dd3c017dc48eb869
https://doi.org/10.1016/j.ijgo.2015.06.054
Zobrazit plný text záznamu
4
The humanistic and economic burden of venous thromboembolism in cancer patients
Autor: J. Relakis, Charalambos Mylonas, Georgia Kourlaba, M.V. Holm, Nikos Maniadakis, Vasiliki Kapaki, Stathis Kontodimas
Publikováno v: Blood Coagulation & Fibrinolysis. 26:13-31
The objective of this study was to present evidence on the epidemiology, health outcomes and economic burden of cancer-related venous thromboembolism (VTE). Medline, Cochrane Central Register of Controlled Trials, Econlit, Science Direct, JSTOR, Oxfo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d7e81c1919d7da53c048382c349a4a
https://doi.org/10.1097/mbc.0000000000000193
Zobrazit plný text záznamu
6
Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema
Autor: G Pantelopoulou, Nikos Maniadakis, Olga Kousidou, Maria Kalogeropoulou, Georgia Kourlaba, J. Relakis, Ronan Mahon
Publikováno v: Cost Effectiveness and Resource Allocation : C/E
Background To conduct a cost-utility analysis of ranibizumab versus aflibercept for the treatment of patients with visual impairment due to diabetic macular edema (DME) in the Greek setting. Methods A Markov model was adapted to compare the use of ra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765a104a168c2d940a86a3e53aa6e784
https://doi.org/10.1186/s12962-016-0056-1
Zobrazit plný text záznamu
7
Everolimus plus exemestane versus bevacizumab-based chemotherapy for second-line treatment of hormone receptor-positive metastatic breast cancer in Greece: An economic evaluation study
Autor: Georgios Koumakis, Nikos Maniadakis, Athanasios Alexopoulos, Vasiliki Rapti, M Chatzikou, Vassilis Georgoulias, Georgia Kourlaba, J. Relakis
Publikováno v: BMC Health Services Research
Background The objective of our study was to conduct a cost-effectiveness (CE) study of combined everolimus (EVE) and exemestane (EXE) versus the common clinical practice in Greece for the treatment of postmenopausal women with HR+/HER2- advanced bre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8249b6dde0f000bf8caec186c6ddee60
https://pubmed.ncbi.nlm.nih.gov/26239115
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje